Crystalline anti-hTNFalpha antibodies

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C436S004000

Reexamination Certificate

active

08034906

ABSTRACT:
The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions.

REFERENCES:
patent: 5231024 (1993-07-01), Meoller et al.
patent: 5656272 (1997-08-01), Le
patent: 6090382 (2000-07-01), Salfeld et al.
patent: 6258562 (2001-07-01), Salfeld et al.
patent: 6448380 (2002-09-01), Rathjen
patent: 6451983 (2002-09-01), Rathjen
patent: 6498237 (2002-12-01), Rathjen
patent: 6509015 (2003-01-01), Salfeld et al.
patent: 7070775 (2006-07-01), Le
patent: 7192584 (2007-03-01), Le
patent: 7223394 (2007-05-01), Salfeld et al.
patent: 7250165 (2007-07-01), Heavner
patent: 7276239 (2007-10-01), Le
patent: 7541031 (2009-06-01), Salfeld et al.
patent: 7588761 (2009-09-01), Salfeld et al.
patent: 7863426 (2011-01-01), Wan et al.
patent: 7919264 (2011-04-01), Maksymowych et al.
patent: 2002/0136719 (2002-09-01), Shenoy et al.
patent: 2003/0012786 (2003-01-01), Teoh et al.
patent: 2003/0049725 (2003-03-01), Heavner
patent: 2003/0161828 (2003-08-01), Abdelghany et al.
patent: 2003/0206898 (2003-11-01), Fischkoff et al.
patent: 2003/0219438 (2003-11-01), Salfeld et al.
patent: 2003/0235585 (2003-12-01), Fischkoff et al.
patent: 2004/0009172 (2004-01-01), Fischkoff et al.
patent: 2004/0033228 (2004-02-01), Krause et al.
patent: 2004/0120952 (2004-06-01), Knight
patent: 2004/0126372 (2004-07-01), Banerjee et al.
patent: 2004/0126373 (2004-07-01), Banerjee et al.
patent: 2004/0131614 (2004-07-01), Banerjee et al.
patent: 2004/0136989 (2004-07-01), Banerjee et al.
patent: 2004/0136990 (2004-07-01), Banerjee et al.
patent: 2004/0136991 (2004-07-01), Banerjee et al.
patent: 2004/0151722 (2004-08-01), Banerjee et al.
patent: 2004/0166111 (2004-08-01), Kaymakcalan et al.
patent: 2004/0219142 (2004-11-01), Banerjee et al.
patent: 2005/0019794 (2005-01-01), Nassef et al.
patent: 2005/0123541 (2005-06-01), Heavner
patent: 2005/0249735 (2005-11-01), Le
patent: 2006/0009385 (2006-01-01), Hoffman et al.
patent: 2006/0018907 (2006-01-01), Le
patent: 2006/0083741 (2006-04-01), Hoffman et al.
patent: 2006/0153846 (2006-07-01), Krause et al.
patent: 2006/0246073 (2006-11-01), Knight
patent: 2007/0003548 (2007-01-01), Heavner
patent: 2007/0041905 (2007-02-01), Hoffman et al.
patent: 2007/0071747 (2007-03-01), Hoffman et al.
patent: 2007/0081996 (2007-04-01), Hoffman et al.
patent: 2007/0172897 (2007-07-01), Maksymowych et al.
patent: 2007/0196373 (2007-08-01), Le
patent: 2007/0202104 (2007-08-01), Banerjee et al.
patent: 2007/0292442 (2007-12-01), Wan et al.
patent: 2007/0298040 (2007-12-01), Le
patent: 2008/0025976 (2008-01-01), Le
patent: 2008/0118496 (2008-05-01), Medich et al.
patent: 2008/0131374 (2008-06-01), Medich et al.
patent: 2008/0166348 (2008-07-01), Kupper et al.
patent: 2008/0193466 (2008-08-01), Banerjee et al.
patent: 2008/0227136 (2008-09-01), Pla et al.
patent: 2008/0292642 (2008-11-01), Borhani et al.
patent: 2008/0311043 (2008-12-01), Hoffman et al.
patent: 2009/0017472 (2009-01-01), Stuhlmuller et al.
patent: 2009/0028794 (2009-01-01), Medich et al.
patent: 2009/0110679 (2009-04-01), Li et al.
patent: 2009/0123378 (2009-05-01), Wong et al.
patent: 2009/0148513 (2009-06-01), Fraunhofer et al.
patent: 2009/0155205 (2009-06-01), Salfeld et al.
patent: 2009/0202557 (2009-08-01), Argiriadi et al.
patent: 2009/0226530 (2009-09-01), Lassner et al.
patent: 2009/0239259 (2009-09-01), Hsieh et al.
patent: 2009/0258018 (2009-10-01), Medich et al.
patent: 2009/0271164 (2009-10-01), Peng et al.
patent: 2009/0280065 (2009-11-01), Willian et al.
patent: 2009/0291062 (2009-11-01), Fraunhofer et al.
patent: 2009/0304682 (2009-12-01), Hoffman et al.
patent: 2009/0317399 (2009-12-01), Pollack et al.
patent: 2010/0003243 (2010-01-01), Okun et al.
patent: 2010/0016557 (2010-01-01), Salfeld et al.
patent: 2010/0021451 (2010-01-01), Wong et al.
patent: 2010/0040604 (2010-02-01), Salfeld et al.
patent: 2010/0040630 (2010-02-01), Elden et al.
patent: 2010/0160894 (2010-06-01), Julian et al.
patent: 2010/0278822 (2010-11-01), Fraunhofer et al.
patent: 2011/0002935 (2011-01-01), Wan et al.
patent: 2011/0054414 (2011-03-01), Shang et al.
patent: WO 97/29131 (1997-08-01), None
patent: WO 02/12502 (2002-02-01), None
patent: WO 02/072636 (2002-09-01), None
patent: WO 2004/009776 (2004-02-01), None
patent: WO 2005/121177 (2005-12-01), None
patent: WO 2006/012500 (2006-02-01), None
patent: WO 2006/069036 (2006-06-01), None
patent: WO 2008/121301 (2008-10-01), None
patent: WO 2009/020654 (2009-02-01), None
McPherson, A. Current Approaches to Macromolecular Crystallization. European Journal of Biochemistry. 1990. vol. 189, pp. 1-23.
Kundrot, C.E. Which Strategy for a Protein Crystallization Project? Cellular Molecular Life Science. 2004. vol. 61, pp. 525-536.
Benevenuti et al., Crystallization of Soluble Proteins in Vapor Diffusion for X-ray Crystallography, Nature Protocols, published on-line Jun. 28, 2007, 2(7):1633-1651.
Cudney R. Protein Crystallization and Dumb Luck. The Rigaku Journal. 1999. vol. 16, No. 1, pp. 1-7.
Drenth, “Principles of Protein X-Ray Crystallography”, 2nd Edition, 1999 Springer-Verlag New York Inc., Chapter 1, p. 1-21.
Ahamed et al. Phase Behaviour of Intact Monoclonal Antibody. Biochemical Journal, Jul. 2007, vol. 93, pp. 610-619.
Baldock, “A comparison of microbatch and vapour diffusion for initial screening of crystallization conditions,”Journal of Crystal Growth, Oct. 1996, vol. 168, No. 1-4, pp. 170-174 (abstact only).
Data Sheet: Drum Rollers—Portable Drum Rotators Drum Mixers, URL<:http://web.archive.org/web/20070117013405/http://www.morsemfgeo.com/products/201-Portable-Drum-Roller.htm>., Jan. 2007 [retrieved on Dec. 2, 2008].
Data Sheet: Fisher Scientific• Hematology/Chemistry Mixer Fisher Scientific, http://www.fishersci.com/, 2008 [Retrieved on Dec. 2, 2008].
Jen et al., “Diamonds in the Rough: Protein Crytsals from a Formulation Perspective,”Pharmaceutical Research, 2001, vol. 18, No. 11, pp. 1483-1488.
McPherson, “A comparison of salts for the crystallization of macromolecules,”Protein Science, 2001, vol. 10, pp. 418-422.
Yang et al., “Crystalline Monoclonal Antibodies for Subcutaneous Delivery,”Proceedings of the National Academy of SciencesJun. 10, 2003. vol. 100, No. 12, pp. 6934-6939.
Baldock, “A comparison of microbatch and vapour diffusion for initial screening of crystallization conditions,”Journal of Crystal Growth, Oct. 1996, vol. 168, No. 1-4, pp. 170-174.
Connell, G. E., et al., “A Human IgG Myeloma Protein Crystallizing with Rhombohedral Symmetry,” Can. J. Biochem., 1973, vol. 51, pp. 1137-1141.
Harris, L. J., et al., “The Three-dimensional Structure of an Intact Monoclonal Antibody for Canine Lymphoma,” Nature, 1992, vol. 360, pp. 369-372.
Huber, R., et al., “Crystallographic Structure Studies of an IgG Molecule and an Fc Fragment,” Nature, 1976, vol. 264, pp. 415-420.
International Preliminary Report on Patentability for Application No. PCT/US08/04006, dated Aug. 28, 2009.
International Search Report for Application No. PCT/US09/000568, dated May 13, 2009.
International Search Report for Application No. PCT/US08/009549, dated Dec. 17, 2008.
International Search Report and Written Opinion for Application No. PCT/US08/04006, dated Jul. 2, 2008.
International Search Report for Application No. PCT/US07/022622, dated Sep. 4, 2008.
Jentoft, J. E., et al., “Characterization of a Human Cryoglobulin Complex: A Crystalline Adduct of a Monoclonal Immunoglobulin G and Albumin,” Biocehmistry, 1982, vol. 21, pp. 289-294.
Jones, H. B., “On a New Substance Occurring in the Urine of a Patient with Mollities Ossium,” Phil. Tr. Royal Soc. London, 1848, vol. 138, pp. 55-62.
Mills, L. E., et al., “Crystallocryoglobulinemia Resulting from Human Monoclonal Anti

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Crystalline anti-hTNFalpha antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline anti-hTNFalpha antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline anti-hTNFalpha antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4292323

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.